Differential inhibition of cardiac and neuronal Na+ channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine

Duloxetine, but not venlafaxine inhibits cardiac Na+-channels with a potency similar to amitriptyline. These data indicate that an inhibition of Na+-channels does not predict a clinically relevant cardiotoxicity.